Atorvastatin prolongs the lifespan of radiation‑induced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect

Yu,Hao; Sun,Shao-Qian; Gu,Xiao-Bin; Wang,Wen; Gao,Xian-Shu

doi:10.3892/or.2017.5447

Atorvastatin prolongs the lifespan of radiation‑induced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect

Authors:
- Hao Yu
- Shao-Qian Sun
- Xiao-Bin Gu
- Wen Wang
- Xian-Shu Gao
View Affiliations

Affiliations: Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing 100034, P.R. China
Published online on: February 14, 2017 https://doi.org/10.3892/or.2017.5447
Pages: 2049-2056

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Studies have reported that atorvastatin (ATO) may increase the radiosensitivity of malignant cells. However, the influence of ATO on reactive oxygen species (ROS) levels before and after irradiation has not been fully illustrated. In the present study, radiosensitivity was evaluated by a clonogenic assay and a cell survival curve and cell apoptosis was measured by flow cytometry. ROS were detected by a laser scanning confocal microscope and flow cytometry with a DCFH-DA probe. NADPH oxidases (NOXs) and superoxide dismutase (SOD) proteins were detected by immunoblotting, and total SOD activity was measured using an SOD kit. We also conducted transient transfection of NOX2 and NOX4 genes to increase intracellular ROS generation and applied SOD mimetic tempol to enhance ROS elimination ability. Our results demonstrated that, with ATO-alone treatment, the survival fractions of irradiated PC-3 cells were significantly decreased. Meanwhile, the apoptosis rate of the irradiated cells increased significantly (P<0.05). The ROS levels of the study group decreased obviously before irradiation (P<0.01), however, the radiation-induced ROS of the study group was at a high level even when irradiation had been terminated for 2 h (P<0.01). Moreover, NOX2 and NOX4 levels and total SOD activity decreased (P<0.01), while the levels of SOD1 were stably maintained (P>0.05). On the other hand, the decreased survival fractions and high radiation-induced ROS levels were abrogated by increasing the level of NOXs by gene transfection or by enhancing the ability of SOD utilizing the addition of tempol. In conclusion, ATO enhanced the cell killing effect of irradiation by reducing endogenous ROS levels and prolonging the lifespan of radiation‑induced ROS via a decrease in the level of NOXs and SOD activity.

View Figures

View References

1	Delaney G, Jacob S, Featherstone C and Barton M: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 104:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
2	Seong KM, Kim CS, Jeon HY, Oh SH, Nam SY, Yang KH, Kim JY and Jin YW: Intrinsic radiosensitivity correlated with radiation-induced ROS and cell cycle regulation. Mol Cell Toxicol. 6:1–7. 2010. View Article : Google Scholar
3	Cooke MS, Evans MD, Dizdaroglu M and Lunec J: Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. 17:1195–1214. 2003. View Article : Google Scholar : PubMed/NCBI
4	Goldstein JL and Brown MS: Regulation of the mevalonate pathway. Nature. 343:425–430. 1990. View Article : Google Scholar : PubMed/NCBI
5	Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R and Mucci LA: Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: A systematic review and meta-analysis. Ann Oncol. 24:1427–1434. 2013. View Article : Google Scholar : PubMed/NCBI
6	He Z, Mangala LS, Theriot CA, Rohde LH, Wu H and Zhang Y: Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells. J Radiat Res (Tokyo). 53:225–233. 2012. View Article : Google Scholar
7	Fritz G, Brachetti C and Kaina B: Lovastatin causes sensitization of HeLa cells to ionizing radiation-induced apoptosis by the abrogation of G2 blockage. Int J Radiat Biol. 79:601–610. 2003. View Article : Google Scholar : PubMed/NCBI
8	Mihăilă RG: Advances in the management of malignant hemopathies: The role of statins. Recent Pat DNA Gene Seq. 7:57–61. 2013. View Article : Google Scholar : PubMed/NCBI
9	Song X, Liu BC, Lu XY, Yang LL, Zhai YJ, Eaton AF, Thai TL, Eaton DC, Ma HP and Shen BZ: Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression. Biochim Biophys Acta. 1843:894–901. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wassmann S, Laufs U, Müller K, Konkol C, Ahlbory K, Bäumer AT, Linz W, Böhm M and Nickenig G: Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 22:300–305. 2002. View Article : Google Scholar : PubMed/NCBI
11	Leith JT, Quaranto L, Padfield G, Michelson S and Hercbergs A: Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: X-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo. Int J Radiat Oncol Biol Phys. 25:283–287. 1993. View Article : Google Scholar : PubMed/NCBI
12	Tucker SL: Parameters of radiosensitivity. Radiat Res. 108:226–229. 1986. View Article : Google Scholar : PubMed/NCBI
13	Oliver R and Shepstone B: Some practical considerations in determining the parameters for multi-target and multi-hit survival curves. Phys Med Biol. 9:167–175. 1964. View Article : Google Scholar
14	Jones KJ, Chetram MA, Bethea DA, Bryant LK, Odero-Marah V and Hinton CV: Cysteine (C)-X-C receptor 4 regulates NADPH oxidase-2 during oxidative stress in prostate cancer cells. Cancer Microenviron. 6:277–288. 2013. View Article : Google Scholar :
15	Verheij M and Bartelink H: Radiation-induced apoptosis. Cell Tissue Res. 301:133–142. 2000. View Article : Google Scholar : PubMed/NCBI
16	Kim GJ, Fiskum GM and Morgan WF: A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability. Cancer Res. 66:10377–10383. 2006. View Article : Google Scholar : PubMed/NCBI
17	Lesser MP: Oxidative stress in marine environments: Biochemistry and physiological ecology. Annu Rev Physiol. 68:253–278. 2006. View Article : Google Scholar : PubMed/NCBI
18	Kumar B, Koul S, Khandrika L, Meacham RB and Koul HK: Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 68:1777–1785. 2008. View Article : Google Scholar : PubMed/NCBI
19	Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A and Pinthus JH: Adiponectin inhibits oxidative stress in human prostate carcinoma cells. Prostate Cancer Prostatic Dis. 15:28–35. 2012. View Article : Google Scholar : PubMed/NCBI
20	Lu JP, Monardo L, Bryskin I, Hou ZF, Trachtenberg J, Wilson BC and Pinthus JH: Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. Prostate Cancer Prostatic Dis. 13:39–46. 2010. View Article : Google Scholar : PubMed/NCBI
21	Deacon J, Peckham MJ and Steel GG: The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 2:317–323. 1984. View Article : Google Scholar : PubMed/NCBI
22	Kryston TB, Georgiev AB, Pissis P and Georgakilas AG: Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 711:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
23	Boonstra J and Post JA: Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene. 337:1–13. 2004. View Article : Google Scholar : PubMed/NCBI
24	Zhang Y and Martin SG: Redox proteins and radiotherapy. Clin Oncol (R Coll Radiol). 26:289–300. 2014. View Article : Google Scholar : PubMed/NCBI
25	Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009. View Article : Google Scholar : PubMed/NCBI
26	Lambeth JD: NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 4:181–189. 2004. View Article : Google Scholar : PubMed/NCBI
27	Goettsch C, Goettsch W, Muller G, Seebach J, Schnittler HJ and Morawietz H: Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun. 380:355–360. 2009. View Article : Google Scholar : PubMed/NCBI
28	Pignatelli P, Carnevale R, Pastori D, Cangemi R, Napoleone L, Bartimoccia S, Nocella C, Basili S and Violi F: Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation. 126:92–103. 2012. View Article : Google Scholar : PubMed/NCBI
29	Nathan C and Cunningham-Bussel A: Beyond oxidative stress: An immunologists guide to reactive oxygen species. Nat Rev Immunol. 13:349–361. 2013. View Article : Google Scholar : PubMed/NCBI
30	Youn HD, Kim EJ, Roe JH, Hah YC and Kang SO: A novel nickel-containing superoxide dismutase from Streptomyces spp. Biochem J. 318:889–896. 1996. View Article : Google Scholar : PubMed/NCBI
31	Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP and Doñate F: Superoxide dismutase 1 (SOD1) is essential for H₂O₂-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci USA. 105:7147–7152. 2008. View Article : Google Scholar : PubMed/NCBI
32	Riley PA: Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 65:27–33. 1994. View Article : Google Scholar : PubMed/NCBI